Hair loss is not a side effect of Jardiance although some medications can lead to hair loss.
Some side effects of Jardiance include
urinary tract infections (UTIs) and fungal (“yeast”) infections of the genitals.
More serious side effects of Jardiance include dehydration, low blood sugar, and serious infection. Ketoacidosis (too much acid in the blood) is also possible but rare.
Jardiance is an antidiabetic medication used to improve glucose control in people with type 2 diabetes.
However Jardiance is not recommended for type 1 diabetes. It is taken by mouth.
Jardiance is a prescription medicine used to: lower blood sugar along with diet and exercise in adults with type 2 diabetes. reduce the risk of cardiovascular death in adults with type 2 diabetes who also have known cardiovascular disease.
In addition to lowering blood sugar and heart-related risks, Jardiance has been found to potentially help with weight loss.
This is an off-label use.
In one study, people with Type 2 diabetes lost an average of more than 2% to 3% of their body weight while taking Jardiance over 24 weeks (close to 6 months).
Steglatro and Jardiance are in the same drug class as each other but the Steglatro is not the same drug as Jardiance.
Jardiance is an oral medication that can be used to lower your blood sugar and also reduce the risk of cardiovascular disease in people with type 2 diabetes alongside other medications, dietary changes, and exercise. It is associated with an increased risk of infections, low blood pressure, and diabetic ketoacidosis.
Steglatro is also an oral diabetes medicine that helps control blood sugar levels.
Ertugliflozin works by helping the kidneys get rid of glucose from your bloodstream.
Steglatro is used together with diet and exercise to improve blood sugar control in adults with type 2 diabetes mellitus.
Steglatro is not for treating type 1 diabetes.